Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)

Summary

  • Epidemiology of HIV-related CVD in developing countries is largely unknown, although long-term data in the ART era are accumulating[Mutimura 2008a; Mutimura 2008b; Syed 2013; Almodovar 2010]
  • Prevention and management of CVD in resource-limited settings is hindered by lack of laboratory infrastructure and specialty management
  • Risk-factor reduction can be challenging because of the stresses of extreme poverty in managing lifestyle changes

Action required